Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study

Abstract

Binswanger's disease is pathologically characterized by a combination of diffuse cerebrovascular white matter lesions and lacunar infarcts in the basal ganglia and white matter. Although a blood-brain barrier (BBB) dysfunction has been implicated in the pathogenesis of these white matter (WM) lesions, few authors have addressed this problem. In the present study, we describe BBB dysfunction and its regional differences in the brains of Binswanger's disease patients. Twelve brains from Binswanger's disease patients (group III) were examined and compared with those from five patients with non-neurological disease (group I) and five cortical infarct patients without significant WM lesions (group II). Immunohistochemistry was performed for glial fibrillary acidic protein and vimentin as astroglial cell markers, and for immunoglobulins, complements and fibrinogen as extravasated serum protein markers. The grading scores for IgG extravasation were significantly higher in group III as compared to group I, in both the periventricular WM and the subcortical WM (P < 0.01). In group III, the scores in the periventricular WM and subcortical WM were significantly higher than in the subcortical U fibers and cerebral cortex (P < 0.01 for the periventricular WM; P < 0.001 for the subcortical WM), respectively. Clasmatodendritic astroglia, which had swollen cell bodies and large cytoplasmic vacuoles with disintegrated processes, incorporated the serum components IgG, IgM, C3d, Clq and fibrinogen, both in the periventricular WM and subcortical WM in 5 out of 12 (42%) Binswanger's disease brains. These results indicate that WM lesions in Binswanger's disease are accompanied by BBB dysfunction, although it remains uncertain whether BBB dysfunction is secondary to either chronic cerebral ischemia or arterial hypertension.

Overview

Integrity signals

Registry

Crossref · 10.1007/s004010050768

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 104

Metadata

Authors
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H.
Affiliations
  • Kyoto University (JP)
  • University of Vienna (AT)
Venue
Acta Neuropathologica
Published
1998-01-12
Volume
95
Issue
1
Pages
78-84
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2081675709
Cited by
104
References
0
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 7 · 2015: 2 · 2014: 8 · 2013: 4 · 2012: 3
FWCI
2.97
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Binswanger disease, blood-brain barrier dysfunction, white matter lesions, lacunar infarction, IgG extravasation, fibrinogen, complement system, periventricular white matter, subcortical white matter, chronic cerebral ischemia, hypertension
MeSH terms
Aged, Blood-Brain Barrier, Complement System Proteins, Dementia, Female, Fibrinogen, Glial Fibrillary Acidic Protein, Humans, Immunoglobulin G, Immunohistochemistry, Male, Middle Aged, Nerve Degeneration, Vimentin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study. https://app.cochat.ai/papers/10.1007/s004010050768
The paper
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1998). Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study. Acta Neuropathologica. https://doi.org/10.1007/s004010050768

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.